Abstract. The present study aimed to explore the mechanisms behind the development and progression of hepatocellular carcinoma (HCC) and identify information regarding HCC-related microRNAs (miRNAs) or marker genes for the gene therapy of HCC. Gene expression profile of GSE67882, generated from 4 hepatitis B virus infected HCC tissue samples (HCC group) and 8 chronic hepatitis B tissue samples with no fibrosis (control group) were downloaded from the Gene Expression Omnibus database. The differentially expressed miRNAs functional enrichment and pathway analyses of HCC were revealed, followed by transcription factor-miRNA interaction network construction and analyses. A total of 14 upregulated miRNAs and 16 downregulated miRNAs between HCC and control samples were obtained. Differentially expressed miRNAs were mainly involved in biological processes like the regulation of histone H3-K9 methylation, and the KEGG pathways in cancer map05200 demonstrates their involvement in cancer. A total of 3 outstanding regulatory networks of miRNAs: hsa-miR-15a, hsa-miR-125b and hsa-miR-122 were revealed. A total of 11 differentially expressed miRNAs including hsa-miR-146p-5b that regulated the marker genes of HCC were explored. miRNAs such as hsa -miR-15a, hsa-miR-125b, hsa-miR-122 and hsa-miR-146b-5p may be new biomarkers for the gene therapy of HCC. Furthermore, histone H3-K9 methylation and other pathways in cancer observed in the KEGG map05200 may be closely related with the development of HCC.
Introduction
Hepatocellular carcinoma (HCC) is a fatal disease (1) . Several types of potentially curative treatments have become available due to the advances in technology and surgical techniques (2) . Despite these advances in the clinical treatment of HCC, the mortality rate remains high (3) . Thus, novel potential therapies for HCC are urgently required.
As potential therapy targets in malignant cells microRNA (miRNA/miR) perform important roles in regulating gene expression (4) . Dysregulation of miRNA is widely involved in human cancer, including HCC (5) . A previous study indicated that the mutation of the miR-122 binding site in the interleukin-1α 3' untranslated region is associated with the incidence rate of HCC (6) . As a potential tumor suppressor miRNA, miR-1285-3p has been shown to regulate the expression of JUN (Jun Proto-Oncogene, AP-1 Transcription Factor Subunit) in the disease progression of HCC (7) . The regulation of feedback between miRNAs and target genes performs important roles in the progression of HCC (8) . Downregulated miR-148b has been shown to be a biomarker for the early detection of HCC (9) . Previous miRNA-based HCC gene therapy studies have demonstrated significant inhibition of miRNA in HCC cells, indicating a promising alternative to current therapeutics (10) (11) (12) . However, the association between miRNA and their target genes, as well as the influence of these associations during the process of HCC is rarely studied.
miRNA expression profiling has proven useful in diagnosing and understanding the development and progression of several diseases including HCC (13) (14) (15) . The use of miRNA expression profiling as a prognostic biomarker for the detection of HCC is practicable (16 Transcription factor-miRNA association investigation. Each miRNA may have several target genes, but outstanding target genes are more likely to assemble transcription factors (24) . Thus, the analysis between transcription factors and miRNA is beneficial to understand this pathomechanism. iRegulon can be used to detect transcription factors, motifs and their optimal sets of direct targets from a set of genes (25) . In the present study, the iRegulon in Cytoscape software was used to explore the potential associations between miRNA and transcription factors. The minimum identity between orthologous genes was 0.05, while the maximum false discovery rate on motif similarity was 0.001. The normalized enrichment score (NES) of >4 was considered as the threshold value for the selection of potential associations.
HCC-associated miRNA investigation. The Comparative
Toxicogenomics Database (CTD) is a robust, publicly available database that is used to advance understanding regarding how environmental exposures affect human health (26) . In the present study, the investigation of HCC-associated miRNA was performed using the CTD database. The biomarkers of a disease are generally identified by gene expression traits, abnormalities in gene structure or mutation which could perform roles in the etiology of a disease. Thus miRNAs which regulate these genes may be important for HCC.
Results

Investigation into differentially expressed miRNAs.
The original data were analyzed and filtered. A total of 14 upregulated miRNAs and 16 downregulated miRNAs were obtained with thresholds of P<0.05 and |log 2 FC|>0.52. The heat map of differentially expressed miRNAs is displayed in Fig. 1 .
Analysis of differentially expressed miRNAs and their associated target genes.
Based on two experimental certificate databases (miRecords and miRWalk), a total of 380 suitable miRNA-target gene relations were obtained. A total of 22 miRNAs including hsa-miR-15a, hsa-miR-125b, hsa-miR-122, hsa-miR-146b-5p and hsa-miR-142-3p were revealed to have experimental certificate target genes. GO and KEGG pathway analysis were used to gain further insights into the pathways significantly involved by miRNAs. GO functional enrichment analysis demonstrated that differentially expressed miRNAs, including hsa-miR-15a and hsa-miR-125b, were mainly involved in the positive regulation of histone H3-K9 methylation (GO, 0051574; BP), fibrillar center (GO, 0001650; CC) and mismatched DNA binding (GO, 0030983; MF; Table I ). KEGG pathway analysis in the present study demonstrated that differentially expressed miRNAs were mainly enriched in the pathways in cancer map05200 (http://www.genome.jp/dbget-bin/www_ bget?pathway:map05200; Fig. 2 ). Based on the experimental certificate miRNA-target gene databases aforementioned, the miRNA-target gene regulatory network was constructed using Cytoscape software. The results demonstrate that there were 13 significantly upregulated miRNAs and 9 significantly downregulated miRNAs (Fig. 3) .
Transcription factor-miRNA relations analysis. The iRegulon in Cytoscape software was used to explore the potential association between miRNA and transcription factors. With NES >4, the 3 miRNAs with the highest number of target genes were hsa-miR-15a (Fig. 4) , hsa-miR-125b (Fig. 5) and hsa-miR-122 (Fig. 6 ). There were 61 target genes that were upregulated by hsa-miR-15a, including transcription factors such as zinc finger protein 143, poly (ADP-ribose) polymerase 1, V-maf musculoaponeurotic fibrosarcoma oncogene homolog K, DNA polymerase epsilon subunit 3, heat shock factor protein 2 and interferon regulatory factor 8. A total of 54 target genes were downregulated by hsa-miR-125b, including transcription factors such as general transcription factor II-I repeat domain-containing protein 1, serum response factor, polymerase (RNA) II (DNA directed) polypeptide A, B-cell lymphoma 6 protein and transcription factor E2F1. A total of 49 target genes were downregulated by hsa-miR-122, including transcription factors such as forkhead box protein A2, CCAAT/enhancer-binding protein α and estrogenassociated receptor γ.
HCC-associated miRNA analysis. A total of 11 differentially expressed miRNA that regulated the marker genes of HCC were identified (Table II) . Among them, hsa-miR-146-5p (n=13), hsa-miR-15a (n=5) and hsa-miR-125b (n=4) were the miRNAs that regulated the highest number of marker genes of HCC. A further investigation was made on other HCC-associated genes (not the marker genes but recorded in databases) in the CTD database. The results indicated that a total of 49 target genes of miR-122 were HCC-associated genes. 
Discussion
HCC is one of the most common types of human cancer worldwide (1). However, the molecular mechanisms behind the pathogenesis and progression of HCC remain unclear.
The present study performed a bioinformatics analysis on the miRNA expression profile of HCC. By screening the differentially expressed miRNAs, a total of 14 upregulated miRNAs and 16 downregulated miRNAs between HCC samples and control samples were obtained. These differentially expressed miRNAs were mainly involved in BP like positive regulation of histone H3-K9 methylation, and were observed in KEGG pathways in cancer map05200. A total of 3 outstanding regulatory networks of miRNA (hsa-miR-15a, hsa-miR-125b and hsa-miR-122) were further investigated. A total of 11 differentially expressed miRNAs that regulated the candidate marker genes of HCC were explored. In the present study, GO enrichment analysis demonstrated that the target genes that were regulated by the differentially expressed miRNA, such as hsa-miR-15a and hsa-miR-125b, were mainly enriched in functions such as histone H3-K9 methylation. DNA methylation and histone H3-K9 modifications perform important roles in the process of tumor formation by the dysregulation of target genes (27) . A previous study demonstrated that H3-K9 methylation contributed to chromosomal targeting of polycomb group proteins (28) . DNA methylation profiling for serum DNA of patients with HCC revealed a potential association between HCC and DNA methylation (29) . Peng et al (30) indicated that heterochromatin (essential for chromosome organization and inheritance) stability requires regulators of histone H3-K9 methylation, which indicates that regulation of histone H3-K9 methylation is vital for cancer-associated gene expression. Thus, the present study speculated that histone H3-K9 modifications may relate to the progression of HCC. KEGG pathway analysis in the present study revealed that target genes of differentially expressed miRNAs were mainly enriched in multiple cellular processes related to cancer and MAPK signaling. Daroqui et al (31) proved that MAPK signaling promotes cell invasiveness and in vivo tumor progression via actin remodeling in response to transforming growth factor-β. Tumor necrosis factor has been revealed to activate the cyclic adenosine monophosphate response element-binding protein through the p38 MAPK/mitogen and stress activated protein kinase 1 signaling pathway (32) . MAPK signaling and pathways in cancer had a close association with HCC processes, and so the differentially expressed miRNA that relate with the MAPK signaling pathway and cancer-related pathways (as determined by KEGG analysis) may take part in the development of HCC.
It is considered that the regulation of transcription factors and miRNAs is essential for the appropriate execution of biological events and developmental processes (33) . By incorporating prior information from predicted regulatory interactions with parallel miRNA/mRNA expression datasets, Peng et al (34) indicated that the transcription factor-miRNA co-regulatory based on feed-forward loops served an important role in the development of prostate cancer. In the present study, the regulatory networks of 3 outstanding miRNAs (hsa-miR-15a, hsa-miR-125b and hsa-miR-122) were obtained. This result demonstrates that these transcription factors had close associations with the 3 miRNAs in the co-regulation of target genes, which further indicated the complex regulatory roles of them during the development of HCC. Thus, it is speculated that hsa-miR-15a, hsa-miR-125b and hsa-miR-122 may be the miRNAs to be investigated for their role in HCC gene therapy.
Human miR-146b-5p is an miRNA which is located on chromosome 10q24.3 (35) . miR-146b-5p is frequently downregulated in solid tumors, including prostate cancer, pancreatic cancer and glioblastoma (36) . In the present study, HCC-associated miRNA analysis revealed that there were 11 differentially expressed miRNAs that regulate the marker genes of HCC including miR-146b-5p, which had the highest number of marker genes. Furthermore, the HCC-associated gene (not recorded marker genes) investigation based on the CTD database revealed that miR-122 had the highest number of HCC-associated genes. A previous study indicated that miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan software (37) . In animal models, miR-122 has been proven to be a marker of liver cell damage, inflammation and regeneration in acetaminophen-induced liver injury (38) . In the present study, miR-122 was revealed to be closely associated with HCC, thus the target gene of miR-122 may be the potential novel marker gene for HCC. Therefore, it was speculated that hsa-miR-15a, hsa-miR-125b, hsa-miR-122 and hsa-miR-146b-5p may perform important roles in the progression of HCC, and may be new biomarkers for gene therapy of HCC. However, there were limitations to the present this study, such as lack of experimental verification and joint analysis of expression profile data. An investigation based on experimental verification is required in future studies.
In conclusion, miRNAs such as hsa-miR-15a, hsa-miR-125b, hsa-miR-122 and hsa-miR-146b-5p may be new biomarkers for gene therapy of HCC. Histone H3-K9 methylation and miRNAs identified through KEGG analysis to be involved in cancer formation may be closely associated with the development of HCC. 
